According to reports on April 20th, Japan Tobacco's subsidiary, Russia Tobacco Company (INTERFAX.RU), is expecting improved financial performance in 2022. The company is the largest tobacco manufacturer in Russia, owned by Japan Tobacco International.
The company reported a revenue of 430.8 billion rubles, representing a 25.4% increase from 2021, with a net profit of 43.5 billion rubles, which grew 1.53 times from the previous year.
The company's tobacco products are manufactured by the "Petro" and "J.T.I. Donskoy Tabak" factories and distributed through the AO TK Megapolis distributor. The company has branches in 25 cities across Russia, with some regions having their own independent branches.
Japan Tobacco International (JTI) holds shares in its Russian subsidiary through JT International Germany GmbH. JTI owns a portfolio of brands, including Winston, LD, Camel, Sobranie, Donskoy Tabak, Kiss, Play, and Peter the Great.
Read more:
Japan Tobacco's sales in South Korea have decreased by 1.3% due to a lack of new distribution channels for its tobacco products.
Japan Tobacco plans to increase its investment in Ploom X and aims to expand coverage to at least 20 countries by the end of 2024.
References:
The Russian subsidiary of Japan Tobacco, known as "Dochka," has increased its net profits by more than 1.5 times in 2022.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
